Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease
Open Access
- 7 August 2023
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 185, 106254
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Science and Technology Support Program of Jiangsu Province
- National Key Research and Development Program of China
This publication has 40 references indexed in Scilit:
- Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction EffectsJAMA Neurology, 2015
- White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutationsMovement Disorders, 2013
- Early‐stage cognitive impairment in Parkinson’s disease and the influence of dopamine replacement therapyEuropean Journal of Neurology, 2011
- The MoCANeurology, 2010
- Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivoNeurology, 2010
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseNew England Journal of Medicine, 2009
- Clinical diagnostic criteria for dementia associated with Parkinson's diseaseMovement Disorders, 2007
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988